How should we best target the biology of ER PR HER2 negative breast cancer?

被引：0
|
作者：
Tutt, A. N. J. [1 ]
Reis-Filho, J. S. [2 ]
机构：
[1] Kings Coll London, Breakthrough Breast Canc Res Unit, London WC2R 2LS, England
[2] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 07期
关键词：
D O I：
10.1016/S1359-6349(08)70703-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：166 / 166
页数：1
相关论文
共 50 条
  • [1] Her2 FISH amplification in ER/PR/Her2 IHC negative breast cancer
    Sahoo, Sunati
    Hwang, Helena
    CANCER RESEARCH, 2015, 75
  • [2] Personalizing Breast Cancer Staging by the Inclusion of ER, PR, and HER2
    Bagaria, Sanjay P.
    Ray, Partha S.
    Sim, Myung-Shin
    Ye, Xing
    Shamonki, Jaime M.
    Cui, Xiaojiang
    Giuliano, Armando E.
    JAMA SURGERY, 2014, 149 (02) : 125 - 129
  • [3] QuantiGene 2.0 Assay for ER, PR and HER2 RNA Levels Is a Useful Adjunctive for the Evaluation of ER, PR and HER2 in Breast Cancer
    Lee, A.
    Chae, B. J.
    Song, B. J.
    Jung, S. S.
    Yim, H. W.
    CANCER RESEARCH, 2009, 69 (24) : 758S - 758S
  • [4] MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer
    Radojicic, Jelena
    Zaravinos, Apostolos
    Vrekoussis, Thomas
    Kafousi, Maria
    Spandidos, Demetrios A.
    Stathopoulos, Efstathios N.
    CELL CYCLE, 2011, 10 (03) : 507 - 517
  • [5] Branched-chain Assay for ER, PR, and HER2 RNA Levels is a Useful Adjunct in the Evaluation of ER, PR, and HER2 in Breast Cancer
    Yim, Hyeon Woo
    Song, Byung Joo
    Jung, Sang Seol
    Kim, Hyun-Joo
    Choi, Yeong-Jin
    Lee, Kyo-Young
    Lee, Ahwon
    JOURNAL OF BREAST CANCER, 2010, 13 (03) : 267 - 274
  • [6] The Genomic Landscape of ER Positive, HER2 Negative Breast Cancer
    Ramakrishna, M.
    Martin, S.
    Campbell, P. J.
    Futreal, P. A.
    Stratton, M. R.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S132 - S132
  • [7] Outcomes of ER, PR, HER2, and triple-negative mutated breast cancer with brain metastasis.
    O'Shea, Patrick Joseph
    Tatineni, Vineeth
    Rauf, Yasmeen
    Jia, Xuefei
    Murphy, Erin Sennett
    Chao, Samuel T.
    Suh, John H.
    Peereboom, David M.
    Ahluwalia, Manmeet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] HOW SHOULD BE THE SURGICAL APPROACH TO HER2 POSITIVE BREAST CANCER?
    Atalay, Can
    JOURNAL OF BREAST HEALTH, 2010, 6 (01): : 1 - 4
  • [9] The molecular pathology of ER, PR HER2 negative breast cancers: finding novel biomarkers
    Reis-Filho, J. S.
    Tutt, A.
    EJC SUPPLEMENTS, 2008, 6 (07): : 166 - 166
  • [10] Molecular Diagnostics in Breast Cancer - Getting Beyond ER, PR, HER2 and Proliferation
    Reis-Filho, J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S21 - S21
12345